Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2013Annals of Surgery

Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MOMinoru OshimaKagawa UniversityKOKeiichi OkanoKagawa University HospitalSMShinobu Muraki

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Oshima et al. (2013) studied this question.

synapsesocial.com/papers/6a784530d8eb58afc2be70abhttps://doi.org/10.1097/sla.0b013e3182827a65
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms1994 · 518 citations
  2. 218F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer2011 · 46 citations
  3. 3Prognostic Value of Immunohistochemical Expression of p53 in Patients with Pancreatic Cancer2009 · 44 citations
  4. 4Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors2012 · 544 citations
  5. 5Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer2011 · 108 citations